Characterization of Childhood-Onset Obsessive-Compulsive Disorder
The Characterization of Childhood Onset Obsessive Compulsive Disorder and the PANDAS Subgroup
2 other identifiers
observational
49
1 country
4
Brief Summary
The purpose of this study is to learn more about Obsessive-compulsive Disorder (OCD) in children. OCD usually has a slow onset, and symptoms that may remain at a stable level over time. A subset of children with OCD has a sudden onset and symptoms that fluctuate in severity over time. This study will also compare healthy children to those with OCD. This is an observational study; children who participate will not receive any new or experimental therapies. OCD affects nearly 1% of the pediatric population. The symptoms of this illness can interrupt development, causing significant psychological distress and producing life-long impairments in social, academic, and occupational functioning. A subgroup of pediatric OCD has been designated by the acronym PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections). This type of OCD is characterized by sudden symptom onset and a relapsing-remitting course of illness; exacerbation of symptoms occurs with scarlet fever or strep. throat infections. This study will identify factors that distinguish children with PANDAS OCD from children with non-PANDAS OCD, and will compare both groups to healthy children. Children with OCD and their parents are screened with interviews and a review of the child's medical records. Participants have an initial evaluation that includes a psychiatric, physical and neuromotor exam, neuropsychological testing, psychological interviews, and a blood test. Structural magnetic resonance imaging (MRS) scans of the brain are also obtained. The MRS scan does not use radiation. After the initial evaluation, children with OCD have follow-up visits every 6 weeks for 12 to 24 months. They are seen yearly for 8 years after the study. If they have a significant improvement or worsening of their symptoms, they are asked to make a maximum of two extra visits. Parents of OCD patients are called four times a year to discuss any changes in the child's condition between yearly visits. All participants have a 1-year follow-up visit upon study completion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2002
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 20, 2002
CompletedFirst Submitted
Initial submission to the registry
August 22, 2002
CompletedFirst Posted
Study publicly available on registry
August 23, 2002
CompletedStudy Completion
Last participant's last visit for all outcomes
May 18, 2010
CompletedJuly 2, 2017
May 18, 2010
August 22, 2002
June 30, 2017
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- OCD Participants (N = 72)
- Aged 4-12 years and living within a four-hour commute from NIH
- Currently meet DSM-IV criteria for OCD.
- Recent onset of symptoms (less than 6 months.)
- Healthy Controls (N = 60-72)
- Age and sex matched to ODC participants.
- Must be free of current or past psychopathology.
You may not qualify if:
- OCD Participants:
- Diagnosis of schizophrenia, schizoaffective, bipolar, delusional, or psychotic disorder; autistic spectrum disorder or pervasive developmental disorder; neurologic disorder other than tics; or rheumatic fever.
- Significant or unstable medical illness.
- Full scale IQ less than 80.
- Healthy Controls:
- Full scale IQ less than 80.
- Significant or unstable medical illness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
University of Arkansas
Little Rock, Arkansas, 72205, United States
University of Florida
Gainesville, Florida, 32610-0296, United States
Cornell University
New York, New York, 10021-4872, United States
Utah State University
Logan, Utah, 84322, United States
Related Publications (3)
Rosenberg DR, Keshavan MS, O'Hearn KM, Dick EL, Bagwell WW, Seymour AB, Montrose DM, Pierri JN, Birmaher B. Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder. Arch Gen Psychiatry. 1997 Sep;54(9):824-30. doi: 10.1001/archpsyc.1997.01830210068007.
PMID: 9294373BACKGROUNDSnider LA, Lougee L, Slattery M, Grant P, Swedo SE. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry. 2005 Apr 1;57(7):788-92. doi: 10.1016/j.biopsych.2004.12.035.
PMID: 15820236BACKGROUNDSaxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl. 1998;(35):26-37.
PMID: 9829024BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
August 22, 2002
First Posted
August 23, 2002
Study Start
August 20, 2002
Study Completion
May 18, 2010
Last Updated
July 2, 2017
Record last verified: 2010-05-18